Home
Jiangsu Vcare PharmaTech Co.

Jiangsu Vcare PharmaTech... Market Share Analysis for May 2026

江苏威凯尔医药科技股份有限公司_专注于创新药物与领先疗法开发创新药物与领先疗法开发

Industry: N/A

Domainvcarepharmatech.com

Year Founded--

Employees501 - 1000

Annual Revenue$2M - $5M

Jiangsu Vcare PharmaTech Co.

Jiangsu Vcare PharmaTech Co. (including company regionals)

vcarepharmatech.com

See more website traffic and engagement information

Jiangsu Vcare PharmaTech Co. Revenue up to May 2026 is 2M - 5M

revenue generated by Jiangsu Vcare PharmaTech Co. top domains

Jiangsu Vcare PharmaTech Co. top domains revenue over 3 years

Revenue for Jiangsu Vcare PharmaTech Co. top domains

vcarepharmatech.com2M - 5M

See more with Sales Intelligence

Total visits to Jiangsu Vcare PharmaTech Co.'s top domains

Understand Jiangsu Vcare PharmaTech Co. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Jiangsu Vcare PharmaTech Co.'s top domains

Analyze Jiangsu Vcare PharmaTech Co. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Jiangsu Vcare PharmaTech Co.'s top domains

See how Jiangsu Vcare PharmaTech Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Jiangsu Vcare PharmaTech Co. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Jiangsu Vcare PharmaTech Co.

These are the website technologies, by industry, used by Jiangsu Vcare PharmaTech Co. top domains

Social (2)

Baidu Share

Mobile (1)

Meta Viewport

Widget (1)

General Captcha

News & Signals from Jiangsu Vcare PharmaTech Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEverest Medicines Limited partnered with Jiangsu Vcare Pharmatech Co.,Ltd on Jun 9th '26.Everest Medicines enters into exclusive Asia-Pacific licensing agreement with Vcare PharmaTech for Sumecigrel.

NewsJiangsu Vcare Pharmatech Co.,Ltd receives financing of $62.9M in Series C.Chinese contract research organisation (CRO) firm Jiangsu Vcare PharmaTech has secured 450 million yuan ($62.9 million) in a Series C funding round, according to a company release.